Ozempic may reduce alcohol craving and consumption, new study finds
A small clinical trial finds semaglutide may help people with alcohol use disorder cut back on drinking and reduce cravings.
Timing of coffee consumption may affect longevity, researchers say
A large study suggests that when you drink your coffee—especially in the morning—may matter more for your health than how much you drink.
Can ibogaine repair brain damage in multiple sclerosis? New case reports spark interest
A new case report describes how two multiple sclerosis patients showed reduced brain lesions and symptom improvement following ibogaine treatment.
Study finds microdosing LSD is not effective in reducing ADHD symptoms
Microdosing LSD has no clear benefit for ADHD, according to a new placebo-controlled clinical trial published in JAMA Psychiatry.
Scientists uncover delayed effects of citalopram on brain’s reward system
Researchers discovered that citalopram temporarily suppresses reward-related brain activity after the first dose but restores it over time, offering insights into antidepressant mechanisms
Ketamine shows promise for treatment-resistant PTSD in psychedelic-style therapy settings
Ketamine therapy, when combined with psychedelic-inspired support, shows strong potential for reducing PTSD symptoms in those who haven’t responded to conventional treatments, new research suggests.
Psychedelics use is linked to lower odds of frequent bad headaches
A study of British adults found that those who had used psychedelics were 25% less likely to report frequent bad headaches, adding to growing research on psychedelics’ potential medical benefits.
Cannabis intoxication alters metabolism, but frequent users show fewer effects
Scientists have identified metabolic changes in the blood linked to cannabis intoxication, revealing key differences between occasional and chronic users.
First human study sheds light on the cognitive and physiological effects of 3-MMC
A recent study has shed light on the effects of a popular designer drug called 3-methylmethcathinone, or 3-MMC.
Caffeine may help rugby players sustain activity and agility in multi-day tournaments
Caffeine may help rugby sevens players sustain effort and agility in tournament play, according to new research.
Coffee does not significantly impact balance or physical function in older adults
A new study finds drinking caffeinated coffee slightly changes how older adults maintain balance but does not significantly affect stability or physical function. A strong cup of coffee is unlikely to increase fall risk.
Psilocybin’s impact on mental wellbeing varies by race, study finds
Does psilocybin affect everyone the same way? New research suggests that race and ethnicity may play a role in the long-term benefits of this psychedelic substance.
Surprising link between cannabis use and cognitive decline uncovered after analyzing decades of data
A study tracking men for 44 years found past cannabis use did not accelerate cognitive decline. Users actually experienced a slightly smaller decline than non-users.
Ayahuasca may enhance memory recollection in experienced users
Recent findings suggest that ayahuasca improves detailed memory recall among experienced users without altering overall familiarity.
Is drinking together more fun? Study sheds light on the science of shared intoxication
Drinking alcohol in social settings is often more enjoyable, and new research explains why: the positive effects of alcohol are actually amplified when your conversation partner is also under the influence.
